Please use this identifier to cite or link to this item: https://observatorio.fm.usp.br/handle/OPI/32469
Full metadata record
DC FieldValueLanguage
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorLOPES, Aline C.
dc.contributor.authorXAVIER, Rafaella F.
dc.contributor.authorPEREIRA, Ana Carolina A. C.
dc.contributor.authorSTELMACH, Rafael
dc.contributor.authorFERNANDES, Frederico L. A.
dc.contributor.authorHARRISON, Samantha L.
dc.contributor.authorCARVALHO, Celso R. F.
dc.date.accessioned2019-06-26T17:29:30Z
dc.date.available2019-06-26T17:29:30Z
dc.date.issued2019
dc.identifier.citationCHRONIC ILLNESS, v.15, n.2, p.138-148, 2019
dc.identifier.issn1742-3953
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/32469
dc.description.abstractObjectives To identify clusters of chronic obstructive pulmonary disease (COPD) patients with distinct beliefs about their illness in terms of symptoms, health-related quality of life (HRQoL), self-efficacy, and daily life physical activity (DLPA). Methods This cross-sectional study included 150 COPD outpatients. The patients' illness perceptions, clinical control, HRQoL, self-efficacy, and DLPA (accelerometry) were evaluated. A cluster analysis was conducted using data from the Illness Perceptions Questionnaire - Revised to establish groups of patients with distinct illness perceptions. Differences between clusters were tested using a T-test or a Mann-Whitney U test. Results The cluster analysis revealed two groups: distressed (n = 95) and coping (n = 55). Despite the fact that both clusters presented similar pulmonary function, between-cluster differences were observed in their self-efficacy, dyspnea, HRQoL, clinical control (p < 0.001), and educational level (p = 0.002). The levels of DLPA did not differ between the clusters. Discussion We observed that clinically stable COPD patients who displayed higher emotional representations and less coherence had heightened symptoms, poorer HRQoL, worse self-efficacy, and lower educational levels. These results emphasize the need to routinely evaluate illness perceptions in COPD patients to target and tailor the proper treatment to improve these important health outcomes.eng
dc.description.sponsorshipSao Paulo Research Foundation (FAPESP) [2016/05968-1, 2013/20676-9]
dc.language.isoeng
dc.publisherSAGE PUBLICATIONS LTDeng
dc.relation.ispartofChronic Illness
dc.rightsrestrictedAccesseng
dc.subjectChronic obstructive pulmonary diseaseeng
dc.subjectillness perceptionseng
dc.subjecthealth-related quality of lifeeng
dc.subjectself-efficacyeng
dc.subjectdyspneaeng
dc.subject.otherquality-of-lifeeng
dc.subject.otherillness perceptionseng
dc.subject.otherpulmonary rehabilitationeng
dc.subject.otheracceptanceeng
dc.subject.otherdiseaseeng
dc.subject.othersenseeng
dc.titleIdentifying COPD patients at risk for worse symptoms, HRQoL, and self-efficacy: A cluster analysiseng
dc.typearticleeng
dc.rights.holderCopyright SAGE PUBLICATIONS LTDeng
dc.identifier.doi10.1177/1742395317753883
dc.identifier.pmid29343090
dc.subject.wosMedicine, General & Internaleng
dc.type.categoryoriginal articleeng
dc.type.versionpublishedVersioneng
hcfmusp.author.externalHARRISON, Samantha L.:Teesside Univ, Sch Hlth & Social Care, Hlth & Social Care Inst, Middlesbrough, Cleveland, England
hcfmusp.description.beginpage138
hcfmusp.description.endpage148
hcfmusp.description.issue2
hcfmusp.description.volume15
hcfmusp.origemWOS
hcfmusp.origem.idWOS:000469358500003
hcfmusp.origem.id2-s2.0-85061018735
hcfmusp.publisher.cityLONDONeng
hcfmusp.publisher.countryENGLANDeng
hcfmusp.relation.referenceBailey PH, 2004, QUAL HEALTH RES, V14, P760, DOI 10.1177/1049732304265973eng
hcfmusp.relation.referenceBekke-Hansen S, 2014, DAN MED J, V61eng
hcfmusp.relation.referenceBestall JC, 1999, THORAX, V54, P581, DOI 10.1136/thx.54.7.581eng
hcfmusp.relation.referenceBrooks SK, 2011, J PSYCHOSOM RES, V71, P411, DOI 10.1016/j.jpsychores.2011.08.001eng
hcfmusp.relation.referenceCharlier C, 2012, EUR J CANCER CARE, V21, P790, DOI 10.1111/j.1365-2354.2012.01362.xeng
hcfmusp.relation.referenceClatworthy J, 2007, PSYCHOL HEALTH, V22, P123, DOI 10.1080/14768320600774496eng
hcfmusp.relation.referenceFischer MJ, 2007, CLIN REHABIL, V21, P212, DOI 10.1177/0269215506070783eng
hcfmusp.relation.referenceFischer M, 2010, BRIT J HEALTH PSYCH, V15, P887, DOI 10.1348/135910710X492693eng
hcfmusp.relation.referenceForman EM, 2012, BEHAV THER, V43, P341, DOI 10.1016/j.beth.2011.07.004eng
hcfmusp.relation.referenceHarrison SL, 2014, RESP MED, V108, P319, DOI 10.1016/j.rmed.2013.10.016eng
hcfmusp.relation.referenceHarrison SL, 2014, CHRONIC ILLN, V10, P31, DOI 10.1177/1742395313493122eng
hcfmusp.relation.referenceJackson Bradford E, 2014, Ann Am Thorac Soc, V11, P310, DOI 10.1513/AnnalsATS.201308-273BCeng
hcfmusp.relation.referenceKaptein AA, 2008, J ASTHMA, V45, P625, DOI 10.1080/02770900802127048eng
hcfmusp.relation.referenceKim Y, 2012, NEPHROL NURS J, V39, P39eng
hcfmusp.relation.referenceLeventhal H, 1984, HDB PSYCHOL HLTH, VIV, P219eng
hcfmusp.relation.referenceMiller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805eng
hcfmusp.relation.referenceMoss-Morris R, 2002, PSYCHOL HEALTH, V17, P1, DOI 10.1080/08870440290001494eng
hcfmusp.relation.referenceMoss-Morris R, 2013, BRIT J HEALTH PSYCH, V18, P681, DOI 10.1111/bjhp.12072eng
hcfmusp.relation.referenceScharloo M, 1998, J PSYCHOSOM RES, V44, P573, DOI 10.1016/S0022-3999(97)00254-7eng
hcfmusp.relation.referenceSchneider G, 2006, AM J GERIAT PSYCHIAT, V14, P850, DOI 10.1097/01.JGP.0000233784.04532.a5eng
hcfmusp.relation.referenceSchwarzer R., 1995, MEASURES HLTH PSYCHO, P35, DOI 10.1037/T00393-000eng
hcfmusp.relation.referenceSHERBOURNE CD, 1991, SOC SCI MED, V32, P705, DOI 10.1016/0277-9536(91)90150-Beng
hcfmusp.relation.referenceSkinner TC, 2011, PSYCHOL HEALTH, V26, P321, DOI 10.1080/08870440903411039eng
hcfmusp.relation.referenceTiemensma J, 2016, INT J CHRONIC OBSTR, V11, P2001, DOI 10.2147/COPD.S109227eng
hcfmusp.relation.referencevan der Molen Thys, 2003, Health Qual Life Outcomes, V1, P13, DOI 10.1186/1477-7525-1-13eng
hcfmusp.relation.referenceVan Remoortel H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039198eng
hcfmusp.relation.referenceWeldam SWM, 2014, BMC FAM PRACT, V15, DOI 10.1186/1471-2296-15-140eng
hcfmusp.relation.referenceWilliams JEA, 2001, THORAX, V56, P954, DOI 10.1136/thorax.56.12.954eng
hcfmusp.relation.referenceYohannes AM, 2000, REV CLIN GERONTOL, V10, P193, DOI 10.1017/S0959259800002100eng
dc.description.indexMEDLINEeng
dc.identifier.eissn1745-9206
hcfmusp.citation.scopus6
hcfmusp.scopus.lastupdate2022-05-06-
Appears in Collections:

Artigos e Materiais de Revistas Científicas - FM/MFT
Departamento de Fisioterapia, Fonoaudiologia e Terapia Ocupacional - FM/MFT

Artigos e Materiais de Revistas Científicas - HC/ICESP
Instituto do Câncer do Estado de São Paulo - HC/ICESP

Artigos e Materiais de Revistas Científicas - HC/ICHC
Instituto Central - HC/ICHC

Artigos e Materiais de Revistas Científicas - HC/InCor
Instituto do Coração - HC/InCor

Artigos e Materiais de Revistas Científicas - LIM/05
LIM/05 - Laboratório de Poluição Atmosférica Experimental

Artigos e Materiais de Revistas Científicas - LIM/54
LIM/54 - Laboratório de Bacteriologia


Files in This Item:
File Description SizeFormat 
art_LOPES_Identifying_COPD_patients_at_risk_for_worse_symptoms_2019.PDF
  Restricted Access
publishedVersion (English)175.89 kBAdobe PDFView/Open Request a copy

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.